-
With Qatar's liquefied natural gas still offline, U.S. companies see an opening and are bringing in new investments.
-
Drug overdose deaths are plummeting in the U.S. in ways never seen before. Experts worry new, toxic "synthetic" street drugs could derail the recovery.
-
Firms like Function Health and Oura market regular blood tests to people wanting to take their health into their own hands. The process often raises more questions for patients than it can answer.
-
An Israeli whose parents were killed on Oct. 7, 2023, and a Palestinian whose brother died from injuries in Israeli custody say they've become like brothers. Their new book is The Future Is Peace: A Shared Journey Across the Holy Land.
-
The prime minister announced new tax cuts to try to end the crisis that began after the U.S.-Israel war on Iran led to the closure of the Strait of Hormuz. The government could face a no-confidence vote over its response to the fuel protests.
-
Websites like youraislopbores.me have become playgrounds for people looking for light relief in a bot-heavy world.
With Virginia on board, the National Popular Vote Compact is now enacted in states worth 222 electoral votes. Here's what that means.
-
Behind the acid blood and jump scares of the Alien franchise is an even more insidious horror: a single employer with unchecked power. How Weyland-Yutani helps explain monopsony — and the rise of inequality on Earth.
-
New evidence finds that sight and imagination rely on the same neurons and use the same neural code.
-
Local TV giant Nexstar's $6.2 billion deal to acquire rival Tegna won speedy approval from Trump administration regulators. But it faces a tough challenge from a pair of antitrust lawsuits.
-
Section 702 of the Foreign Intelligence Surveillance Act is responsible for a huge share of intel collected by the U.S. Lawmakers and civil liberties advocates are worried it enables warrantless spying on U.S. citizens.
-
Diplomats from Israel and Lebanon will meet in Washington for rare direct talks.